All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @dr.notms on TikTok · 57s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @dr.notms's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:04So like people like getting pregnant on Ozempic like have we found the miracle for infertility?
  2. 0:11So let's pause and think so
  3. 0:15Preacher researchers think that Ozempic may be interacting with birth control methods
  4. 0:21But also we know that weight loss is associated with improved fertility
  5. 0:26Especially in women suffering with PCOS polycystic ovarian syndrome now
  6. 0:32We still need more studies right Ozempic may interfere with baby. So if you're pregnant
  7. 0:36You should stop immediately, but if you do not plan to become pregnant in addition to birth control
  8. 0:41I recommend barrier protection so you have an extra layer
  9. 0:44But some of us might not want that side effect, you know, so
  10. 0:49Just saying but hey go to gateway direct help calm and let's schedule a discovery call so we can talk more about these weight loss medicines

Ozempic and unintended pregnancy: what the 'Ozempic babies' trend gets right and wrong

Gabwilliamsmd

TikTok creator

2.7K viewsWatch on TikTok

Quick answer

Semaglutide (Ozempic, Wegovy) can improve ovulatory function in women with PCOS through weight-loss-mediated hormonal normalization, which may explain increased unintended pregnancies in this population. The drug theoretically reduces oral contraceptive absorption via delayed gastric emptying, but clinical data confirming meaningful contraceptive failure rates from this mechanism are lacking. Semaglutide is not approved in pregnancy and should be discontinued at least two months prior to conception, ideally with a provider-managed transition plan.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Ozempic and unintended pregnancy: what the 'Ozempic babies' trend gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Ozempic and unintended pregnancy: what the 'Ozempic babies' trend gets right and wrong" from Gabwilliamsmd. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semaglutide (Ozempic, Wegovy) can improve ovulatory function in women with PCOS through weight-loss-mediated hormonal normalization, which may explain increased unintended pregnancies in this population.

The reason this review is not generic is the source wording and the canonical claim label "glp1 they just keep finding more and more effects of ozempic ya l." In this clip, the useful excerpt is: "So like people like getting pregnant on Ozempic like have we found the miracle for infertility?" That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Novo Nordisk's prescribing information acknowledges that semaglutide may reduce absorption of oral medications due to delayed gastric emptying, but no large clinical trial has confirmed this causes oral contraceptive failure at a meaningful rate.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Semaglutide (Ozempic, Wegovy) can improve ovulatory function in women with PCOS through weight-loss-mediated hormonal normalization, which may explain increased unintended pregnancies in this population.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semaglutide (Ozempic, Wegovy) can improve ovulatory function in women with PCOS through weight-loss-mediated hormonal normalization, which may explain increased unintended pregnancies in this population. The drug theoretically reduces oral contraceptive absorption via delayed gastric emptying, but clinical data confirming meaningful contraceptive failure rates from this mechanism are lacking. Semaglutide is not approved in pregnancy and should be discontinued at least two months prior to conception, ideally with a provider-managed transition plan.
  • A 2019 meta-analysis (Lim et al., Human Reproduction Update) found that 5-10% weight loss restores ovulation in a meaningful proportion of overweight women with PCOS, which is the most evidence-supported explanation for increased pregnancies among Ozempic users.
  • Novo Nordisk's prescribing information acknowledges that semaglutide may reduce absorption of oral medications due to delayed gastric emptying, but no large clinical trial has confirmed this causes oral contraceptive failure at a meaningful rate.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • A 2019 meta-analysis (Lim et al., Human Reproduction Update) found that 5-10% weight loss restores ovulation in a meaningful proportion of overweight women with PCOS, which is the most evidence-supported explanation for increased pregnancies among Ozempic users.
  • Novo Nordisk's prescribing information acknowledges that semaglutide may reduce absorption of oral medications due to delayed gastric emptying, but no large clinical trial has confirmed this causes oral contraceptive failure at a meaningful rate.
  • The FDA recommends discontinuing semaglutide before pregnancy. Current clinical guidelines from ACOG suggest stopping at least two months before a planned conception.
  • Animal reproduction studies with semaglutide showed fetal harm at doses above human therapeutic range. Human pregnancy safety data remains limited as of 2024.
  • The 'Ozempic babies' effect is most likely driven by restored ovulation in women with PCOS or obesity-related anovulation, not by birth control failure from drug interaction.
  • Adding barrier contraception as a backup for oral contraceptive users on GLP-1 medications is a reasonable precaution given the theoretical interaction, but it should be discussed with a prescriber rather than adopted based on a TikTok recommendation.
  • Semaglutide is not approved as a fertility treatment. Any patient hoping to use it for that purpose should have a full evaluation by a reproductive endocrinologist.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @dr.notms actually say?

The creator claimed that semaglutide (Ozempic) may interact with hormonal birth control, that weight loss from the drug can improve fertility especially in women with PCOS, and that anyone not trying to get pregnant should add barrier protection on top of existing contraception. They also stated that people who are pregnant should "stop immediately." These are the core claims worth examining.

To their credit, they acknowledged the evidence is not settled, saying "we still need more studies." That caveat matters. But the video still presents a fairly confident clinical recommendation, complete with a plug for a telehealth discovery call, which is worth keeping in mind when evaluating how this information is packaged and delivered.

Does the science back this up?

Partially, yes. The fertility angle for PCOS patients is the strongest part of this video. The birth control interference claim is plausible but still speculative, and the "stop immediately if pregnant" advice is directionally right but too blunt.

On PCOS: weight loss consistently improves hormonal profiles in women with PCOS, restoring ovulation in women who previously had irregular cycles. A 2019 meta-analysis by Lim et al. in Human Reproduction Update confirmed that even modest weight loss (5-10%) significantly improved ovulation rates and pregnancy outcomes in overweight women with PCOS. Semaglutide, by driving that weight loss, could plausibly contribute to this effect.

On birth control interference: the mechanism proposed is that GLP-1 receptor agonists slow gastric emptying, which could theoretically reduce absorption of oral contraceptives. This is biologically plausible. Novo Nordisk's prescribing information for Ozempic does note a potential interaction with oral medications due to delayed gastric emptying. However, a 2022 pharmacokinetic study by Hausner et al. in Clinical Pharmacokinetics found that semaglutide had a relatively small effect on oral contraceptive exposure, and its clinical significance remains uncertain. The creator overstates certainty here.

What did they get wrong (or right)?

They got the PCOS-fertility connection right. That link is well-supported and relevant to the audience asking why people are getting pregnant on Ozempic. Credit where it is due.

What they got wrong, or at least imprecise: the birth control interference claim is presented as a likely mechanism when the clinical evidence is thin. Saying researchers "think" Ozempic may be interacting with birth control methods is accurate as a description of a hypothesis, but the way it lands in a short TikTok video is that this is an established risk. It is not.

The "stop immediately if pregnant" advice is also more complicated than presented. The FDA advises discontinuing semaglutide during pregnancy, yes. But "stop immediately" without mentioning the need to consult a provider first is the kind of oversimplification that can cause harm, especially for patients managing type 2 diabetes who may need a transition plan.

Finally, the creator is a telehealth provider with a call-to-action embedded in this video. That does not make the information wrong, but it is worth noting that the recommendation to add barrier protection is framed as clinical advice delivered without a full patient history.

What should you actually know?

If you are using hormonal birth control and taking a GLP-1 medication, talk to your prescriber. The theoretical interaction with oral contraceptives exists in the pharmacology, but it has not been shown to cause a clinically meaningful increase in unintended pregnancies in large studies. The "Ozempic babies" phenomenon is more likely explained by restored ovulation in women with PCOS or obesity-related anovulation than by birth control failure.

If you are pregnant or planning to become pregnant, GLP-1 receptor agonists are not approved for use during pregnancy. The current recommendation from the FDA and most clinical guidelines is to discontinue these medications at least two months before a planned pregnancy. Animal studies have shown fetal harm at high doses, though human data is limited. Do not stop or start any medication during pregnancy without speaking to your OB or prescriber first.

The broader takeaway: semaglutide's effects on fertility are real but are mostly indirect, driven by weight loss and hormonal normalization rather than any direct action on reproductive tissue. This is a plausible and interesting area of ongoing research, not a settled fertility treatment.

Bottom line

This video is not misinformation, but it is imprecise in ways that matter. The PCOS and fertility connection is solid. The birth control interference claim is speculative. The clinical recommendations are directionally reasonable but lack the nuance a patient deserves. If your TikTok feed is your primary source of reproductive health guidance, that is the bigger problem to solve.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Gabwilliamsmd · TikTok creator

2.7K views on this video

They just keep finding more and more effects of Ozempic… Ya’ll be safe out there. This is the second reason to put on a condom- catch the live @drnylander and I did on Tuesday to learn the first reason! #ozempicbabies #weightloss #primarycare

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about a 2019 meta-analysis (lim et al., human reproduction update) found?

A 2019 meta-analysis (Lim et al., Human Reproduction Update) found that 5-10% weight loss restores ovulation in a meaningful proportion of overweight women with PCOS, which is the most evidence-supported explanation for increased pregnancies among Ozempic users.

What does the video say about novo nordisk's prescribing information acknowledges?

Novo Nordisk's prescribing information acknowledges that semaglutide may reduce absorption of oral medications due to delayed gastric emptying, but no large clinical trial has confirmed this causes oral contraceptive failure at a meaningful rate.

What does the video say about the fda recommends discontinuing semaglutide before pregnancy. current clinical guidelines?

The FDA recommends discontinuing semaglutide before pregnancy. Current clinical guidelines from ACOG suggest stopping at least two months before a planned conception.

What does the video say about animal reproduction studies with semaglutide showed fetal harm at doses?

Animal reproduction studies with semaglutide showed fetal harm at doses above human therapeutic range. Human pregnancy safety data remains limited as of 2024.

What does the video say about the 'ozempic babies' effect?

The 'Ozempic babies' effect is most likely driven by restored ovulation in women with PCOS or obesity-related anovulation, not by birth control failure from drug interaction.

What does the video say about adding barrier contraception as a backup for?

Adding barrier contraception as a backup for oral contraceptive users on GLP-1 medications is a reasonable precaution given the theoretical interaction, but it should be discussed with a prescriber rather than adopted based on a TikTok recommendation.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Gabwilliamsmd, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.